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Abstract We demonstrate the establishment of transgenic mice,
where the expression of the green fluorescent protein (GFP) is
under control of the human cardiac K-actin promoter. These mice
display cardiac specific GFP expression already during early
embryonic development. Prominent GFP fluorescence was
observed at the earliest stage of the murine heart anlage (E8).
Cardiomyocytes of different developmental stages proved GFP
positive, but the intensity varied between cells. We further show
that contractions of single GFP positive cardiomyocytes can be
monitored within the intact embryo. At later stages of embryonic
development, the skeletal musculature was also GFP positive, in
line with the known expression pattern of cardiac K-actin. The
tissue specific labeling of organs is a powerful new tool for
embryological as well as functional investigations in vivo.
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1. Introduction
The heart is one of the ¢rst organs to form during murine
development. Between E7.5 and 8 the generation of a single
heart tube is initiated and on E 8.5/9 the ¢rst contractions of
this primitive structure are observed [1]. Due to the small size
of the embryo and the relatively di⁄cult isolation procedure,
embryological and particularly functional investigations on
the whole heart as well as on isolated cardiomyocytes at these
very early developmental stages have so far been impossible
[2,3]. The discovery of the green £uorescent protein (GFP)
originally derived from the jelly¢sh Aequorea victoria has
opened a new era for the in vivo labeling of organs and cells
[4,5]. GFP has proven an almost ideal in vivo reporter gene,
because it does not interfere with cell vitality [6^8], it is highly
sensitive and it can be easily detected using £uorescence mi-
croscopy [9,10]. The generation of transgenic mice expressing
GFP [7] or the enhanced version of GFP (EGFP) [8] under
control of the ubiquitously expressed L-actin promoter has
proved the feasibility of this approach. Since transcripts of
K-cardiac actin are among the earliest detectable in the devel-
oping heart of murine embryos [11], we have employed the K-
cardiac actin promoter driven GFP reporter gene for the gen-
eration of transgenic mice. The construct used was ¢rst tested
in the ES cell system, where GFP £uorescence was detected
speci¢cally in ES cell derived cardiomyocytes already prior to
the initiation of spontaneous contractions (E. Kolossov et al.,
unpublished results) ; identical results have been reported us-
ing Lac-Z as the reporter gene [12].
Here we demonstrate tissue speci¢c GFP expression very
early during murine cardiomyogenesis. In later stage embryos
and newborn mice, GFP expression was also detected in the
skeletal musculature. We propose that this novel approach
will prove very helpful for the investigation of embryonic
development. In addition, the cardiac GFP expression allows
to the best of our knowledge for the ¢rst time the easy mor-
phological and functional investigation of the very early em-
bryonic heart in vivo.
2. Materials and methods
2.1. Construction of vector
The vector pPv/B-Act-lacZ containing the (3440 +6) segment of
the human cardiac K-actin promoter [13,14] was provided by Dr.
McBurney (University of Ottawa, Canada). The pCX-h-EGFP ex-
pression vector containing the enhanced version of the GFP coding
sequence EGFP (Clontech) under the chicken L-actin promoter [8]
was provided by Dr. Okabe (University of Osaka, Japan). The pro-
moter was excised from pPv/B-Act-lacZ by SalI and HindIII restric-
tion enzymes. The pCX-EGFP was digested with SnaBI and ApaI
restriction endonucleases in order to excise the chicken L-actin pro-
moter which was replaced by the SalI-HindIII fragment of the cardiac
K-actin promoter by blunt-end ligation yielding the pCX-(K-act)-
EGFP vector. The CMV enhancer, of the original vector, was left
in its position upstream of the speci¢c promoter.
2.2. Production of transgenic mice
Transgenic mice were generated as described before [15]. Brie£y,
transgenic mouse lines were established by injecting the puri¢ed Bam-
HI-SalI fragment of pCX-(K-act)-EGFP into the pronuclei of outbred
Him:OF1Uoutbred Him:OF1 [16] fertilized eggs. In total, 234 DNA
injected eggs were transferred into the oviducts of pseudo-pregnant
mice, resulting in 23 newborns. The integration of the transgene was
investigated by PCR analysis of samples of the mouse tails. PCR was
carried out as described elsewhere [17]. The sequences of the primers
against the EGFP gene used were 5P ACA AGT TCA GCG TGT
CCG GC-3P and 5P TTG TGG CTG TTG TAG TTG TAC TCC
AG-3P for the forward and reverse primers, respectively. The temper-
ature pro¢le of the PCR reaction was 30 s 95‡C, 40 s 64‡C and 1 min
72‡C for 25 cycles after an initial denaturing step of 5 min 95‡C.
2.3. Observation of the green £uorescence
F1 animals were generated by mating male hemizygous transgenic
mice with female wild type animals. Large numbers of F1 animals
were produced using standard superovulation protocols. The screen-
ing of GFP positive embryos and newborn F1 pups from each trans-
genic founder mouse was performed using a £uorescence microscope
or a lamp with a transcutaneous ¢beroptic illumination light source
(wavelength optimum, 470 nm) and spectacles with a LP ¢lter (520
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nm) (Volpi). For the investigation of the GFP expression at the blas-
tocyst stage, E3.5 blastocysts were collected from the uteri of females
mated with hemizygous founder males and placed into microdrops of
M 16 medium [18,19]. Photographs (F-601-AF camera, Nikon, Japan)
of the blastocysts were taken by placing them under a £uorescent
microscope (Diaphot 300, Nikon) and using Nikon excitation (450^
490 nm, Nikon) and emission ¢lters (520 nm). The blastocysts were
cultured for a period up to 6 days in M 16 medium (37‡C, 5% CO2)
and screened every day under £uorescent light for £uorescence.
For the investigation of GFP positive embryos and neonatal pups a
Zeiss microscope (Axiophot, Zeiss, Germany) and a Zeiss £uorescence
¢lter set (number 9) were used. Frequently the combination of £uo-
rescence and transmitted light was employed. Pictures were taken
immediately after harvesting the embryos or the hearts of postnatal
mice (for detail see ¢gure legends). For the morphological analysis,
murine embryos and isolated hearts from embryos as well as neonatal
mice were immersion ¢xed in a solution containing 4% paraformalde-
hyde in 0.1 M PBS bu¡er, pH 7.4 for 15 min to 4 h. Under these
conditions tissue conservation proved good and GFP expression re-
mained stable at 4‡C for weeks, although a slight shift of the £uo-
rescence emission towards longer wavelength (yellow) was noticed.
After embedding in 18% sucrose for cryoprotection embryos/hearts
were cryosected (5^15 Wm thickness). GFP negative embryos and neo-
nates were used as controls. Their background £uorescence was neg-
ligible and di¡ered strongly from the GFP £uorescence emitted by
their transgenic littermates. For the functional analysis embryos
were kept in standard PBS solution. At least ¢ve GFP positive and
GFP negative animals of each developmental stage presented in the
manuscript were investigated. Pictures of the whole embryos and the
hearts were taken prior to immersion ¢xation. Live video images of
the spontaneously contracting heart were recorded using a three chip
color CCD camera (Sony, Japan) and stored on a SVHS video record-
er (Panasonic, USA). Single images were imported into a computer
based morphometric software program (Optimas, Germany) via an
interface. Quantitative morphometric analysis was performed on an
array of continuous imaging sequences.
3. Results and discussion
DNA analysis by PCR revealed six transgenic founder ani-
mals, where the GFP expression was under the control of the
human cardiac K-actin promoter (K-actin EGFP mice). The
integration frequency, i.e. transgenic mice/newborn animals,
was 26%. Four transgenic founders transmitted the gene con-
struct to their o¡spring. The transgenic lines #93 and #111
were investigated in greater detail in this study. Hemizygous
male F0 animals were mated with wild type females and the
o¡spring were analyzed as described below. GFP positive
transgenic embryos and neonatal mice displayed a strong £u-
orescent signal in the chest upon exposure to a £uorescent
transcutaneous illumination light source. About 50% of the
littermates of the lines #93 (n = 54, four litters) and #111
(n = 56, ¢ve litters) proved positive for the transgene product
as determined by direct screening of the £uorescence of F1
animals. Thus, the gene construct was transmitted according
to the Mendelian rules of inheritance for a single integration
site. Hemizygous as well as homozygous K-actin EGFP mice
of both lines were viable and fertile. In addition, intrauterine
fetuses as well as adult hemizygous mice were investigated. No
pathophysiological side e¡ects on development, growth per-
formance or body weight were detected.
In clear contrast to the chicken L-actin EGFP transgenic
mice [8], embryos from wild type mothers and hemizygous
males from both lines of our K-actin EGFP mice did not
show £uorescence at the morula (n = 30) and blastocyst
(n = 84) stages. Moreover, cultivation of the blastocysts in
vitro did not evidence £uorescent signals after 6 days of culti-
vation (n = 18) (data not shown). Starting from the earliest
murine heart anlage (E8) cardiac speci¢c GFP expression
was observed in murine embryos positive for the EGFP trans-
gene (Fig. 1). At this stage the heart still had the typical
tubular structure and the cardiomyocyte wall showed a patchy
pattern of GFP content; however, no obvious di¡erences in
GFP £uorescence intensity between the atrial and ventricular
tubes were noticed (Fig. 1). During the subsequent stages of
cardiac di¡erentiation, the heart remained strongly GFP pos-
itive. As depicted in Fig. 2A,B combination of transmitted
light and blue £uorescence excitation evidenced in an E9
(A) and E10 (B) embryo an intensely £uorescent heart, where-
as the remaining embryo displayed almost no or only little
FEBS 21227 7-12-98 Cyaan Magenta Geel Zwart
Fig. 1. Fluorescence picture of an E8 K-actin EGFP mouse embryo. The primitive heart tube within the embryo is strongly £uorescent. The
heart shows a patchy pattern of GFP expression, since not all cardiomyocytes are GFP positive.
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Fig. 2. Combined transmitted and £uorescence excitation light pictures of early stage K-actin EGFP mouse embryos. The GFP £uorescence in
an E9 and an E10 embryo is restricted to the heart. A: The GFP positive heart in an E9 embryo displays the tubular-like structure characteris-
tic for this early di¡erentiation stage (magni¢cation U26). B: The GFP positive heart of an E10 embryo already shows the chamber-like for-
mation as expected for this developmental stage (magni¢cation U26).
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£uorescent signal. As expected for the early embryonic stage
E9, the heart still maintained the primitive tubular structure
(Fig. 2A). In contrast, the heart of an E10 embryo already
showed the organization into chambers (Fig. 2B). At these
early stages of embryonic development, whole embryos were
dissociated using collagenase treatment and single cardiomyo-
cytes were identi¢ed based on their £uorescence (data not
shown). As depicted in Fig. 3A,B in an E15 embryo, both
atria and ventricles were £uorescent upon exposure to blue
excitation light. The GFP expression at this stage was inho-
mogeneous with the atria being more strongly £uorescent than
the ventricles. All cardiomyocytes of both atria and ventricles
were GFP positive, but the individual degree of GFP expres-
sion varied considerably even among cells of the same region
(Fig. 3B), most likely related to various degrees of cardiac K-
actin synthesis in cardiomyocytes (Fig. 3B). In line with our
¢ndings in middle to late embryonic stages, the early postnatal
heart was characterized by a similar pattern of GFP expres-
sion. As shown in Fig. 4 the di¡erence in £uorescence inten-
sity between atria and ventricles at 4 days after birth was less
pronounced as compared to E15 (Fig. 4A,B). At a higher
magni¢cation the pattern of the GFP expression in individual
ventricular cardiomyocytes was cross striation-like (Fig. 4D).
Since the coronary vessels lack any £uorescence, they can be
easily identi¢ed on the whole heart (Fig. 4A). This can be
explained by the absence of the transgene product in eryth-
rocytes and the prominent £uorescence quench by the Fe2
containing hemoglobin in these cells. This ¢nding is in line
with the L-actin EGFP transgenic mice, where the spleen was
not £uorescent due to the high content in erythrocytes [8].
Histological cross sections of the murine heart demonstrated
that the coronary vessels (Fig. 4B), the endocardium as well as
the epicardium were GFP negative, underlining the tissue spe-
ci¢c GFP expression in these transgenic mice. In accordance
with previous ¢ndings using in situ hybridization techniques
[20], where cardiac K-actin was expressed in both cardiac and
skeletal muscle, our mice displayed GFP expression in the
skeletal musculature at the embryonic as well as postnatal
stages. The ¢rst GFP £uorescence in skeletal muscle was de-
tected with somite formation on E10^E11. However, the heart
was the only organ prior to E11 to express large amounts of
GFP. In clear contrast to the L-actin (E)GFP transgenic mice
[7,8], the GFP expression in our EGFP K-actin mouse was
almost restricted to cardiac and skeletal musculature. Faint
£uorescence was observed in other tissues. It is currently
under investigation whether this background is due to pro-
moter activity or GFP metabolism.
Since the embryo at the E8^E10 stage is transparent and the
heart strongly £uorescent, the beating heart could be observed
in the embryo. The hearts continued to spontaneously con-
tract for hours after harvesting of the embryos. As can be seen
in Fig. 5, single GFP positive cardiomyocytes in an E9 em-
bryo were easily distinguishable and the contractile activity
during one contraction cycle was monitored within the intact
embryo. The degree of contraction of this myocyte amounted
to a 20% reduction in cell length. These experiments prove the
feasibility in the future of monitoring chronotropy, degree of
contraction as well as inotropy (estimation of shortening ve-
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Fig. 3. Fluorescence pictures taken of an E15 K-actin EGFP mouse embryo. A: The dissected heart is photographed from ventral. A clear dif-
ference in the £uorescence intensity between the auricola and the ventricles is visible (magni¢cation U28). B: The sagittary cross section of this
heart evidences further the clear di¡erence in the GFP expression between the atrial and the ventricular walls (magni¢cation U18).
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Fig. 4. Fluorescence pictures of the heart from a 4 day old K-actin EGFP mouse. A: The whole heart is photographed in the open chest. Atrial
and ventricular musculature display an intense GFP £uorescence. No £uorescence signal is detected in parts of the atrium and in coronary ves-
sels (magni¢cation U20). B: Sagittal cryosection of the heart displayed in A. Atria and ventricles display comparable £uorescence intensities
and expression patterns for GFP. Crossection of the coronary vessels demonstrated the absence of GFP £uorescence (arrows). The vessel wall
is not visible due to the absence of GFP expression (magni¢cation U20). C: A representative segment of the ventricle, where the distinct di¡er-
ences of the GFP expression between cardiomyocytes can be observed (magni¢cation U39). D: 1940U magni¢cation of the framed segment in
C. Single ventricular cardiomyocytes evidence a speci¢c pattern of GFP £uorescence similar to cross striation.
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locity) of the very early embryonic heart at the single cell level
under control conditions and after application of various
pharmacological agents.
In conclusion, the overall GFP expression pattern in our K-
actin EGFP transgenic mice di¡ers strongly from that de-
tected in the L-actin GFP and EGFP transgenic mice [7,8],
as would be expected for a tissue speci¢c promoter. While
blastocysts and morulae are GFP negative, prominent GFP
expression is already detected in the initial heart anlage (E8).
This is in line with in situ hybridization experiments, where
the ¢rst transcripts for cardiac K-actin were detected at E7.5
[11,20]. During later developmental stages the heart remains
GFP positive, but also the skeletal musculature expresses
GFP. Tissue speci¢c GFP expression under various promoters
has been reported for Drosophila [21] and zebra¢sh [22]. How-
ever, in contrast to ubiquitous [7,8] or cell speci¢c [23,24] GFP
expression in transgenic mice, we here show to the best of our
knowledge for the ¢rst time the generation of transgenic mice
with organ/tissue speci¢c GFP expression.
Transgenic mice with GFP as a reporter of gene expression
provide a new powerful tool to address a variety of relevant
biological questions. The high sensitivity of GFP [25] and its
easy mode of detection make this reporter gene far superior to
the currently used ones. We demonstrate in the present manu-
script that the strong GFP expression in the very early murine
embryonic heart allows (i) easy identi¢cation of the heart, (ii)
investigation of morphological and functional characteristics
in the intact embryo, (iii) functional analysis of single cardi-
omyocytes in the spontaneously beating heart, and (iv) dissec-
tion and enzymatic dissociation of the whole embryo for mo-
lecular biological and functional studies on single
cardiomyocytes. In addition, our mice will prove helpful for
the investigation of KO mice with defects of early cardiomyo-
genesis. Thus, the generation of transgenic mice where the
GFP expression is under control of tissue speci¢c promoters
is a powerful approach to address a variety of biological ques-
tions.
Acknowledgements: We thank Dr. M. Okabe (University of Osaka,
Japan) and Dr. J. Miyazaki (Tohoku University, Japan) for kindly
providing the expression vector (pCX-h-EGFP), and Dr. M.W.
McBurney (University of Ottawa, Canada) for supplying us with
the pHCActLacZ (3440^+6) segment of the human cardiac K-actin
promoter.
References
[1] Fishman, M.C. and Chien, K.R. (1997) Development 124, 2099^
2117.
[2] Davies, M.P., An, R.H., Doevendans, P., Kubalak, S., Chien,
K.R. and Kass, R.S. (1996) Circ. Res. 78, 15^25.
[3] Hescheler, J., Fleischmann, B.K., Lentini, S., Maltsev, V.A.,
Rohwedel, J., Wobus, A.M. and Addicks, K. (1997) Cardiovasc.
Res. 36, 149^162.
[4] Prasher, D.C., Eckenrode, V.K., Ward, W.W., Prendergast, F.G.
and Cormier, M.J. (1992) Gene 111, 229^233.
[5] Misteli, T. and Spector, D.L. (1997) Nature Biotechnol. 15, 961^
964.
[6] Gubin, A.N., Reddy, B., Njoroge, J.M. and Miller, J.L. (1997)
Biochem. Biophys. Res. Commun. 236, 347^350.
[7] Ikawa, M., Kominami, K., Yoshimura, Y., Tanaka, K., Nishi-
mune, Y. and Okabe, M. (1995) FEBS Lett. 375, 125^128.
[8] Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. and Nishi-
mune, Y. (1997) FEBS Lett. 407, 313^319.
[9] Brand, A. (1995) Trends Genet. 11, 324^325.
[10] Pines, J. (1995) Trends Genet. 11, 326^327.
[11] Lyons, G.E., Buckingham, M.E. and Mannherz, H.G. (1991)
Development 111, 451^454.
[12] Metzger, J.M., Lin, W.I. and Samuelson, L.C. (1996) Circ. Res.
78, 547^552.
[13] Minty, A. and Kedes, L. (1986) Mol. Cell Biol. 6, 2125^2136.
[14] Pari, G., Jardine, K. and McBurney, M.W. (1991) Mol. Cell.
Biol. 11, 4796^4803.
[15] Brem, G., Brenig, B., Goodman, H.M., Selden, R.C., Graf, F.,
Kru¡, B., Springman, K., Hondele, J., Meyer, J. and Winnacker,
J.-L. (1985) Zuchthygiene 20, 251^252.
FEBS 21227 7-12-98 Cyaan Magenta Geel Zwart
Fig. 5. Fluorescence video images taken of single spontaneously
contracting cardiomyocytes during a contraction cycle in the whole
heart of an E9 K-actin EGFP embryo. A small cluster of strongly
£uorescent cardiomyocytes is depicted. The full bar to the right cor-
responds to the individual cell length before contraction. The cell
length (see numbers on ¢gure) is estimated by morphometric analy-
sis of the video image. A: Cardiomyocytes before contraction. B:
Cardiomyocytes during maximal contraction. The longer cross bars
indicate the actual length, the shorter ones the original cell length.
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